Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia
NCT02339038
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
600
Enrollment
NIH
Sponsor class
Conditions
HCV HIV
Interventions
DRUG:
Ledipasvir 90 mg and Sofosbuvir 400 mg
Sponsor
National Institutes of Health Clinical Center (CC)